Trident Texofab Limited (BOM:540726)

Trident Texofab Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1.12	1.09	1.08	0.62	0.39
Short-Term Investments	-	30.02	-	-	-
Cash & Short-Term Investments	1.12	31.1	1.08	0.62	0.39
Cash Growth	-96.41%	2774.31%	75.65%	58.76%	12.79%
Accounts Receivable	485.54	407.09	366.73	338.73	308.54
Other Receivables	-	15.48	15.81	17.05	15.19
Receivables	485.54	435.08	382.54	355.78	323.73
Inventory	205.65	159.57	135.48	106.39	72.71
Prepaid Expenses	-	0.07	0.04	0.06	0.09
Other Current Assets	91.77	111.62	1.9	4.03	3.35
Total Current Assets	784.07	737.44	521.04	466.88	400.26
Property, Plant & Equipment	175.56	200.84	217.36	233.31	253.33
Long-Term Investments	74.9	18.95	37.4	36.4	20.59
Long-Term Deferred Charges	-	0.87	0.61	0.63	0.75
Other Long-Term Assets	62.93	47.66	42.57	35.87	34.96
Total Assets	1,112	1,006	818.98	773.07	709.88

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	130.51	148.57	166.91	176.23	113.87
Accrued Expenses	-	16.6	24.59	9.94	9.76
Short-Term Debt	-	162.52	162.43	131.39	131.34
Current Portion of Long-Term Debt	204.56	28.16	29.86	29.33	23.43
Current Portion of Leases	2.64	2.64	2.64	2.4	2.4
Current Income Taxes Payable	-	6.91	3.57	1	-
Other Current Liabilities	34.34	42.11	32.81	22.06	21.7
Total Current Liabilities	372.05	407.5	422.81	372.34	302.49
Long-Term Debt	131.46	74.29	177.36	188.76	220.24
Long-Term Leases	27.93	28.42	28.86	28.72	28.93
Long-Term Unearned Revenue	11.63	14.93	16.25	17.67	18.91
Pension & Post-Retirement Benefits	-	2.83	-	-	-
Long-Term Deferred Tax Liabilities	10.17	5.4	11.12	13.8	9.72
Other Long-Term Liabilities	2.5	0	-0	0	-
Total Liabilities	555.75	533.37	656.4	621.29	580.29

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	149.96	135.59	100.7	100.7	100.7
Additional Paid-In Capital	-	209.32	-	-	-
Retained Earnings	405.87	86.38	61.88	51.08	28.89
Comprehensive Income & Other	-	41.1	-	-	-
Total Common Equity	555.82	472.39	162.58	151.78	129.6
Shareholders' Equity	555.82	472.39	162.58	151.78	129.6
Total Liabilities & Equity	1,112	1,006	818.98	773.07	709.88

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	366.59	296.03	401.15	380.6	406.33
Net Cash (Debt)	-365.47	-264.93	-400.07	-379.98	-405.94
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-28.01	-22.65	-39.73	-37.73	-40.31
Filing Date Shares Outstanding	15.46	13.56	10.07	10.07	10.07
Total Common Shares Outstanding	15.46	13.56	10.07	10.07	10.07
Working Capital	412.02	329.94	98.23	94.53	97.77
Book Value Per Share	35.96	34.84	16.14	15.07	12.87
Tangible Book Value	555.82	472.39	162.58	151.78	129.6
Tangible Book Value Per Share	35.96	34.84	16.14	15.07	12.87
Buildings	-	39.77	39.77	39.77	39.77
Machinery	-	218.77	218.81	219.02	186.37
Construction In Progress	-	-	-	-	36.22

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error